Results 31 to 40 of about 1,292,372 (416)
Post-Synthetic Treatment of Nickel-Iron Layered Double Hydroxides for the Optimum Catalysis of the Oxygen Evolution Reaction [PDF]
npj 2D Mater Appl 5, 73 (2021), 2022 Nickel-iron layered double hydroxide (NiFe LDH) platelets with high morphological regularity and sub-micrometre lateral dimensions were synthesized using a homogeneous precipitation technique for highly efficient catalysis of the oxygen evolution reaction (OER).
arxiv +1 more source
Reproductive Biology and Endocrinology, 2004 Background Platelet-activating factor and nitric oxide may be involved in the initiation of human labour as inflammatory mediators. The aim of this study was to test whether platelet-activating factor and lipopolysaccharide were able to induce nitric ...
Seyffarth Gunter +5 more
doaj +1 more source
Radiation therapy generates platelet-activating factor agonists [PDF]
, 2016 Pro-oxidative stressors can suppress host immunity due to their ability to generate oxidized lipid agonists of the platelet-activating factor-receptor (PAF-R).
Chin-Sinex, Helen Jan +13 more
core +2 more sources
Structure and thermodynamics of platelet dispersions [PDF]
Molec. Phys. 106, 1975 (2008), 2008 Various properties of fluids consisting of platelike particles differ from the corresponding ones of fluids consisting of spherical particles because interactions between platelets depend on their mutual orientations. One of the main issues in this topic is to understand how structural properties of such fluids depend on factors such as the shape of ...
arxiv +1 more source
Detection of Platelet-Activating Antibodies Associated with Vaccine-Induced Thrombotic Thrombocytopenia by Flow Cytometry: An Italian Experience [PDF]
, 2022 Rare cases of thrombocytopenia and thrombosis after anti-COVID-19 adenovirus-associated mRNA vaccines (VITT) due to platelet-activating anti-platelet-factor 4 (PF4)/polyanion antibod-ies have been reported. VITT laboratory diagnosis, similarly to heparin-
Angela Rogolino +8 more
core +1 more source
Molecular Pharmacology, 2009 Platelet-activating factor (PAF) is a potent, bioactive phospholipid that acts on multiple cells and tissues through its G protein-coupled receptor (GPCR). PAF is not stored but is rapidly generated via enzymatic acetylation of the precursor 1-O-hexadecyl-2-hydroxy-sn-glycero-3-phosphocholine (lysoPAF). The bioactivity of PAF is effectively and tightly
Zhenyu Li +9 more
openaire +4 more sources
LIS1 and platelet-activating factor acetylhydrolase (Ib) catalytic subunits, expression in the mouse oocyte and zygote [PDF]
, 1999 Platelet-activating factor is a phospholipid with several documented roles in the pre-implantation embryo. Enzymes that belong to the platelet-activating factor acetylhydrolases family inactivate platelet-activating factor.
Cahana, Aviv, Reiner, Orly
core +1 more source
The platelet-activating factor acetylhydrolase of mouse platelets
Biochimica et Biophysica Acta (BBA) - Biomembranes, 1997 Platelet-activating factor (PAF) acetylhydrolases are a family of distinct enzymes with the common property of hydrolyzing and inactivating PAF. It has been shown that the structure and the biochemical behavior of these enzymes depend on their cellular origin.
Angeliki P Karpouza +1 more
openaire +3 more sources
Frontiers in Oncology, 2020 Epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase widely expressed in cervical tumors, being correlated with adverse clinical outcomes. EGFR may be activated by a diversity of mechanisms, including transactivation by G-protein coupled
Juliana L. Souza +6 more
doaj +1 more source
Platelet-activating factor receptor (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database [PDF]
, 2019 Platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) is an ether phospholipid mediator associated with platelet coagulation, but also subserves inflammatory roles.
Hills, Rebecca +8 more
core +2 more sources